By Drug Target Review2025-08-06T10:40:09
Scientists at Ghent University have discovered that a simple combination of vitamin B1 and glucose could drastically improve survival in sepsis – a life-threatening condition responsible for millions of deaths each year.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-30T09:54:00Z
2025-07-30T08:00:00
Sponsored by Wuxi Biologics
2023-01-20T14:24:55
Sponsored by Leica Microsystems
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2023-03-28T11:38:32
Sponsored by Bio-Techne
2023-03-23T14:46:21
Sponsored by Bio-Techne
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud